SCM

Silverarc Capital Management Portfolio holdings

AUM $489M
This Quarter Return
+11.91%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$173M
AUM Growth
+$173M
Cap. Flow
+$22.9M
Cap. Flow %
13.3%
Top 10 Hldgs %
38.32%
Holding
115
New
19
Increased
26
Reduced
33
Closed
31

Top Buys

1
FULC icon
Fulcrum Therapeutics
FULC
$5.24M
2
COGT icon
Cogent Biosciences
COGT
$4.03M
3
CERS icon
Cerus
CERS
$3.66M
4
ARVN icon
Arvinas
ARVN
$3.06M
5
NXTC icon
NextCure
NXTC
$2.94M

Top Sells

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$4.01M
2
MORF
Morphic Holding, Inc. Common Stock
MORF
$2.61M
3
MSAC
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$2.57M
4
RNLX
Renalytix plc American Depositary Shares
RNLX
$1.79M
5
CRIS icon
Curis
CRIS
$1.55M

Sector Composition

1 Healthcare 93.23%
2 Financials 4.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AKLI
51
DELISTED
Akili, Inc. Common Stock
AKLI
$1.06M 0.6% 106,000 -144,000 -58% -$1.43M
DNAB
52
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$1.05M 0.59% 106,000 -144,000 -58% -$1.42M
DNAD
53
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$1.04M 0.59% 106,000 -144,000 -58% -$1.41M
CRNX icon
54
Crinetics Pharmaceuticals
CRNX
$2.92B
$1.04M 0.59% +49,382 New +$1.04M
PROK icon
55
ProKidney
PROK
$319M
$1.04M 0.59% 106,000 -144,000 -58% -$1.41M
ATHA icon
56
Athira Pharma
ATHA
$15.3M
$998K 0.56% 106,388 -11,592 -10% -$109K
MREO
57
Mereo BioPharma
MREO
$272M
$885K 0.5% 365,661 -40,210 -10% -$97.3K
RNLX
58
DELISTED
Renalytix plc American Depositary Shares
RNLX
$742K 0.42% 37,000 -89,145 -71% -$1.79M
NTLA icon
59
Intellia Therapeutics
NTLA
$1.22B
$664K 0.38% +4,950 New +$664K
EVGN icon
60
Evogene
EVGN
$10.9M
$656K 0.37% 248,327 -112,927 -31% -$298K
DRNA
61
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$626K 0.35% 31,040 -198,852 -86% -$4.01M
PNT
62
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$552K 0.31% +71,729 New +$552K
CYBN
63
Cybin
CYBN
$176M
$549K 0.31% +250,000 New +$549K
GH icon
64
Guardant Health
GH
$8.41B
$527K 0.3% 4,218 -455 -10% -$56.8K
CABA icon
65
Cabaletta Bio
CABA
$133M
$511K 0.29% +42,022 New +$511K
ISEE
66
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$487K 0.28% +30,000 New +$487K
CRIS icon
67
Curis
CRIS
$20.9M
$486K 0.27% 62,070 -197,469 -76% -$1.55M
AYLA
68
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$464K 0.26% 40,956 +17,592 +75% +$199K
CALA
69
DELISTED
Calithera Biosciences, Inc
CALA
$406K 0.23% 186,245 +154,863 +493% +$338K
KROS icon
70
Keros Therapeutics
KROS
$618M
$396K 0.22% +10,000 New +$396K
SURF
71
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$379K 0.21% 50,000 -44,539 -47% -$338K
RAPT icon
72
RAPT Therapeutics
RAPT
$188M
$366K 0.21% 11,796 -35,398 -75% -$1.1M
XENE icon
73
Xenon Pharmaceuticals
XENE
$2.98B
$297K 0.17% +19,432 New +$297K
ARCT icon
74
Arcturus Therapeutics
ARCT
$462M
$297K 0.17% +6,208 New +$297K
AFMD
75
DELISTED
Affimed
AFMD
$292K 0.17% 47,182 -155,008 -77% -$959K
1 2
3
4 5